Graeme Milligan
Cited by
Cited by
Identification of a serotonin/glutamate receptor complex implicated in psychosis
J González-Maeso, RL Ang, T Yuen, P Chan, NV Weisstaub, ...
Nature 452 (7183), 93-97, 2008
Heterotrimeric G‐proteins: a short history
G Milligan, E Kostenis
British journal of pharmacology 147 (S1), S46-S55, 2006
Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1–A2A receptor heteromers
F Ciruela, V Casadó, RJ Rodrigues, R Luján, J Burgueno, M Canals, ...
Journal of Neuroscience 26 (7), 2080-2087, 2006
Tailoring cAMP-signalling responses through isoform multiplicity
MD Houslay, G Milligan
Trends in biochemical sciences 22 (6), 217-224, 1997
G protein–coupled receptor oligomerization revisited: functional and pharmacological perspectives
S Ferré, V Casadó, LA Devi, M Filizola, R Jockers, MJ Lohse, G Milligan, ...
Pharmacological reviews 66 (2), 413-434, 2014
G protein-coupled receptor dimerization: function and ligand pharmacology
G Milligan
Molecular pharmacology 66 (1), 1-7, 2004
G-protein–coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor
E Kostenis, G Milligan, A Christopoulos, CF Sanchez-Ferrer, ...
Circulation 111 (14), 1806-1813, 2005
Building a new conceptual framework for receptor heteromers
S Ferré, R Baler, M Bouvier, MG Caron, LA Devi, T Durroux, K Fuxe, ...
Nature chemical biology 5 (3), 131-134, 2009
Antibodies directed against synthetic peptides distinguish between GTP-binding proteins in neutrophil and brain.
P Goldsmith, P Gierschik, G Milligan, CG Unson, R Vinitsky, HL Malech, ...
Journal of Biological Chemistry 262 (30), 14683-14688, 1987
The dynamic role of palmitoylation in signal transduction
G Milligan, M Parenti, AI Magee
Trends in biochemical sciences 20 (5), 181-186, 1995
International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1,-2, and-3: pharmacology and pathophysiological functions
LA Stoddart, NJ Smith, G Milligan
Pharmacological reviews 60 (4), 405-417, 2008
Inverse agonism: pharmacological curiosity or potential therapeutic strategy?
G Milligan, RA Bond, M Lee
Trends in pharmacological sciences 16 (1), 10-13, 1995
G protein‐coupled receptor hetero‐dimerization: contribution to pharmacology and function
G Milligan
British journal of pharmacology 158 (1), 5-14, 2009
The experimental power of FR900359 to study Gq-regulated biological processes
R Schrage, AL Schmitz, E Gaffal, S Annala, S Kehraus, D Wenzel, ...
Nature communications 6 (1), 10156, 2015
δ-opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2
FR McKenzie, G Milligan
Biochemical Journal 267 (2), 391-398, 1990
Techniques used in the identification and analysis of function of pertussis toxin-sensitive guanine nucleotide binding proteins.
G Milligan
Biochemical Journal 255 (1), 1, 1988
Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer: the human δ-opioid receptor …
M McVey, D Ramsay, E Kellett, S Rees, S Wilson, AJ Pope, G Milligan
Journal of Biological Chemistry 276 (17), 14092-14099, 2001
Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective
G Milligan
Molecular pharmacology 64 (6), 1271-1276, 2003
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers
JP Pin, R Neubig, M Bouvier, L Devi, M Filizola, JA Javitch, MJ Lohse, ...
Pharmacological reviews 59 (1), 5-13, 2007
Allostery at G protein-coupled receptor homo-and heteromers: uncharted pharmacological landscapes
NJ Smith, G Milligan
Pharmacological reviews 62 (4), 701-725, 2010
The system can't perform the operation now. Try again later.
Articles 1–20